Latest stories on CAMP
CAMP4 Therapeutics to Host Virtual Analyst Day to Discuss CMP-002 for the Treatment of SYNGAP1-Related Disorder on September 28, 2026
GlobeNewswire56 · neutralproduct/pr
CAMP4 Therapeutics to Host Virtual Analyst Day to Discuss CMP-002 for the Treatment of SYNGAP1-Related Disorder on September 28, 2026
Business Insider56 · neutralproduct/pr
CAMP4 to Participate in Upcoming Investor Conferences
GlobeNewswire56 · neutralgeneral
Camp4 Therapeutics GAAP EPS of -$0.58 misses by $0.37
Seeking Alpha34 · bearishearnings
Camp4 Therapeutics Corp (CAMP) files 8-K
SEC 8-K50 · neutralgeneral
ContractorHUB and CompanyCam Enter Integration Partnership, Reimagining the Potential of Every Jobsite Photo
PR Newswire66 · bullishproduct/pr
CAMP4 Therapeutics Secures $50 Million Private Financing
TipRanks24 · bearishgeneral
Camp4 Therapeutics Corp (CAMP) files 8-K
SEC 8-K50 · neutralgeneral
CAMP4 Therapeutics Announces Second Closing of $100 Million Private Placement
Business Insider24 · bearishgeneral
CAMP4 Moves Into Human Trials -- The Upside Is Underpriced
Seeking Alpha73 · bullishproduct/pr
CAMP4’s CMP-002 Trial Gets Green Light in Australia, Unlocking $50 Million for SYNGAP1 Disorder Research
July 27, 2026
MarketChameleon73 · bullishproduct/pr
Camp4 Therapeutics Corp (CAMP) files 8-K
SEC 8-K50 · neutralgeneral
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
StockTitan50 · neutralgeneral
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Business Insider50 · neutralgeneral
Is CAMP4 THERAPEUTICS CORPORATION (CAMP) Stock Undervalued Ahead of Key CMP-002 Clinical Development Milestones?
Yahoo Finance63 · neutralanalyst
CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | CAMP Stock News
StockTitan50 · neutralgeneral
Camp4 Therapeutics Corp (CAMP) files 8-K
SEC 8-K50 · neutralgeneral
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | CAMP Stock News
StockTitan42 · neutralgeneral